Catalent Opens New Full-Service Clinical Supply Facility in Shiga, Japan

The 6,000 square-meter site will provide flexible clinical supply solutions, serving both local and global biotech and p...

October 10, 2021 | Sunday | News
Japan identifies emerging infectious disease caused by new 'nairovirus'

A previously unknown virus that can infect humans and cause disease has been identified by scientists in Japan. The nove...

October 8, 2021 | Friday | News
Japan's Olympus sets-up corporate venture capital fund

Japan-based Olympus Corporation is establishing Olympus Innovation Ventures, LLC as a corporate venture capital fund. I...

October 5, 2021 | Tuesday | News
Israel's CytoReason introduces AI clinical drug development platform to Japan's pharma market

CytoReason, an AI company developing computational disease models for discovery and clinical drug development, and Summi...

September 30, 2021 | Thursday | News
Japan's Fujifilm promotes industrial application of iPS cell-derived regenerative medicine

Japan-based FUJIFILM Corporation has reached agreement on core terms with Australian regenerative medicine venture Cynat...

October 4, 2021 | Monday | News
Japan to commercialize next-gen Hunter Syndrome therapy

Japanese firms Takeda Pharmaceutical Company and JCR Pharmaceuticals have announced a geographically-focused exclusive c...

October 1, 2021 | Friday | News
"Stem cell-based therapeutics poised to become mainstream option”

To make the trial investments more meaningful and to avoid ambivalence in animal models, medical science is adopting nov...

October 1, 2021 | Friday | News
New osteoporotic bone loss kit enters Japanese market

US-based AgNovos Healthcare and Japanese firm Asahi Kasei Pharma Corporation have entered into an exclusive option agree...

September 30, 2021 | Thursday | News
Aptamer brings Optimer binders-based technology for Japanese scientists

UK-based Aptamer Group and BizCom Japan, Inc., a Japan-based trading and consultancy company, have entered into a distri...

September 28, 2021 | Tuesday | News
Japan approves first and only antibody-drug conjugate (ADC) to treat Urothelial Cancer

Astellas Pharma Inc. and Seagen Inc. announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved P...

September 27, 2021 | Monday | News
Japan approves first orally administered therapy for rare autoimmune renal disease

Swiss firm Vifor Fresenius Medical Care Renal Pharma (VFMCRP) has announced that Japan’s Ministry of Health and La...

September 27, 2021 | Monday | News
Japan's Takeda Pharma picks new partners to help strengthen health systems in LMICs

Japanese firm Takeda Pharmaceutical has announced the addition of four partnerships to its Global Corporate So...

September 23, 2021 | Thursday | News
Japan sets eyes on rare pediatric liver diseases

US-based Mirum Pharmaceuticals, Inc. and Japanese firm Takeda Pharmaceutical have entered into an exclusive licensing ag...

September 22, 2021 | Wednesday | News
Japan's Olympus unveils advanced bipolar surgical energy products

Olympus Corporation has announced the launch of the first devices in the new POWERSEAL™ family of advanced bipolar...

September 21, 2021 | Tuesday | News
Innovative home dialysis therapies to support Japan's growing needs

German firm Fresenius Medical Care has announced a strategic distribution partnership with JMS Co. Ltd, a provider of me...

September 17, 2021 | Friday | News
Japan finds molecular code that powers up cancer-fighting immune cells

A synthetic molecular code shows promise towards improving the response of some cancer patients to immunotherapy treatme...

September 15, 2021 | Wednesday | News
Kyowa Kirin addresses sepsis-associated acute kidney injury in Japanese population

The Netherlands based AM-Pharma B.V. and Japanese firm Kyowa Kirin have entered into an exclusive license agre...

September 14, 2021 | Tuesday | News
French firm Poxel launches type 2 diabetes drug in Japan

French firm POXEL SA along with its partner, Sumitomo Dainippon Pharma,  is launching TWYMEEG (Imeglimin hydro...

September 10, 2021 | Friday | News
Japan's TANAKA holdings encourage overseas medical startups by investment opportunities

TANAKA Kikinzoku Kogyo K.K. which is a subsidiary of TANAKA Holdings Co., Ltd. and operates the TANAKA Precious Metals m...

September 9, 2021 | Thursday | News
US-based CLRO firm Advanced Clinical continues APAC expansion

Advanced Clinical, a global clinical research services organization (CLRO), has announced that the company’s globa...

September 9, 2021 | Thursday | News
Japan to benefit from personalized stem cell banking service expansion by I Peace

I Peace, Inc., a Palo Alto-based biotech startup focusing on Nobel Prize-winning technology of induced pluripo...

September 8, 2021 | Wednesday | News
Japan buys 150 M doses of Novavax COVID-19 vaccine

Takeda Pharmaceutical has announced that the Government of Japan’s Ministry of Health, Labour and Welfare (MH...

September 8, 2021 | Wednesday | News
Japan lays focus on early detection of heart diseases

Japanese firms Astellas Pharma Inc., Nitto Denko Corporation, and M. Heart Co., have announced that the three companies ...

September 6, 2021 | Monday | News
Japan's Fujifilm sells radiopharma biz to PeptiDream for 30.5 billion yen

Japan-based Fujifilm Corporation has announced the transfer of the radiopharmaceutical business of Fujifilm Toyama Chemi...

September 3, 2021 | Friday | News
Rapid acceleration of medical education in Japan using virtual reality

At many Japanese institutions offering medical education, students are unable to attend clinical practice due to the spr...

September 2, 2021 | Thursday | News